Key Takeaways From Twist Bioscience Analyst Ratings
Portfolio Pulse from Benzinga Insights
Analysts' ratings for Twist Bioscience (NASDAQ:TWST) have varied from bullish to bearish over the last quarter. The average 12-month price target has increased by 12.1% to $50.12. Key analysts have raised their price targets, reflecting positive sentiment towards the company's future performance.
June 28, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts' ratings for Twist Bioscience (NASDAQ:TWST) have shown a positive trend with an average 12-month price target increase of 12.1% to $50.12. Key analysts have raised their price targets, reflecting positive sentiment towards the company's future performance.
The increase in the average 12-month price target by 12.1% and the positive adjustments by key analysts indicate a bullish sentiment towards Twist Bioscience. This is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100